The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes
Open accessAbstract
Chemokines have crucial roles in organ development and orchestration of leukocyte migration. The chemokine CCL22 is expressed constitutively at high levels in the lymph node, but the functional significance of this expression is so far unknown. Studying a newly established CCL22-deficient mouse, we demonstrate that CCL22 expression by dendritic cells (DCs) promotes the formation of cell–cell contacts and interaction with regulatory T cells (T reg) through their CCR4 receptor. Vaccination of CCL22-deficient mice led to excessive T cell responses that were also observed when wild-type mice were vaccinated using CCL22-deficient DCs. Tumor-bearing mice with CCL22 deficiency showed prolonged survival upon vaccination, and further, CCL22-deficient mice had increased susceptibility to inflammatory disease. In conclusion, we identify the CCL22–CCR4 axis as an immune checkpoint that is crucial for the control of T cell immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Brahmer, J., Reckamp, K. L., Baas, P., Crinò, L., Eberhardt, W. E. E., Poddubskaya, E., Antonia, S., Pluzanski, A., Vokes, E. E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504627 · Cited by 8,447
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,367
Merad, M., Sathe, P., Helft, J., Miller, J., & Mortha, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074950 · Cited by 2,309
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1806 · Cited by 2,085
Clinicopathologic study of dextran sulfate sodium experimental acute colitis
Shichijo, K., Matuu, M., Ikeda, Y., Naito, S., Ito, M., & Sekine, I. (1998) · Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)41298-5 · Cited by 1,943
T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases
Mempel, T. R., Henrickson, S. E., & von Andrian, U. H. (2004) · Nature · doi:10.1038/nature02238 · Cited by 1,714
Self-citationC hemokines in I nnate and A daptive H ost D efense : Basic Chemokinese Grammar for Immune Cells
Rot, A., & von Andrian, U. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104543 · Cited by 1,215
Self-citationGunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., & Nakano, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.451 · Cited by 1,019
Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease
Lahl, K., Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G., Hamann, A., Wagner, H., Huehn, J., & Sparwasser, T. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061852 · Cited by 924
Iellem, A., Mariani, M., Lang, R., Recalde, H., Panina-Bordignon, P., Sinigaglia, F., & D'Ambrosio, D. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.847 · Cited by 914
Castellino, F., Huang, A. Y., Altan-Bonnet, G., Stoll, S., Scheinecker, C., & Germain, R. N. (2006) · Nature · doi:10.1038/nature04651 · Cited by 855
Regulatory T cells: how do they suppress immune responses?
Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P., & Yamaguchi, T. (2009) · International Immunology · doi:10.1093/intimm/dxp095 · Cited by 854
Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.
Shen, Z., Reznikoff, G., Dranoff, G., & Rock, K. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2723 · Cited by 846
The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
Campbell, J. J., Haraldsen, G., Pan, J., Rottman, J., Qin, S., Ponath, P., Andrew, D. P., Warnke, R., Ruffing, N., Kassam, N., et al. (1999) · Nature · doi:10.1038/23495 · Cited by 841
Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice
Tang, Q., Adams, J. Y., Tooley, A. J., Bi, M., Fife, B. T., Serra, P., Santamaria, P., Locksley, R. M., Krummel, M. F., & Bluestone, J. A. (2006) · Nature Immunology · doi:10.1038/ni1289 · Cited by 774
Onishi, Y., Fehervari, Z., Yamaguchi, T., & Sakaguchi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711106105 · Cited by 716
Sugiyama, D., Nishikawa, H., Maeda, Y., Nishioka, M., Tanemura, A., Katayama, I., Ezoe, S., Kanakura, Y., Sato, E., Fukumori, Y., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316796110 · Cited by 627
NLRP3 inflammasome activity is negatively controlled by miR-223
Bauernfeind, F., Rieger, A., Schildberg, F. A., Knolle, P. A., Schmid-Burgk, J. L., & Hornung, V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201516 · Cited by 544
Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo
Tadokoro, C. E., Shakhar, G., Shen, S., Ding, Y., Lino, A. C., Maraver, A., Lafaille, J. J., & Dustin, M. L. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050783 · Cited by 527
Continuous requirement for the TCR in regulatory T cell function
Levine, A. G., Arvey, A., Jin, W., & Rudensky, A. Y. (2014) · Nature Immunology · doi:10.1038/ni.3004 · Cited by 521
Misra, N., Bayry, J., Lacroix-Desmazes, S., Kazatchkine, M. D., & Kaveri, S. V. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4676 · Cited by 477
Sather, B. D., Treuting, P., Perdue, N., Miazgowicz, M., Fontenot, J. D., Rudensky, A. Y., & Campbell, D. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070081 · Cited by 406
Macrophage-derived Chemokine Is a Functional Ligand for the CC Chemokine Receptor 4
Imai, T., Chantry, D., Raport, C. J., Wood, C. L., Nishimura, M., Godiska, R., Yoshie, O., & Gray, P. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1764 · Cited by 378
Lee, I., Wang, L., Wells, A. D., Dorf, M. E., Ozkaynak, E., & Hancock, W. W. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041709 · Cited by 371
Cytokines and chemoattractants in allergic inflammation
Romagnani, S. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00013-5 · Cited by 331
CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells
Schneider, M. A., Meingassner, J. G., Lipp, M., Moore, H. D., & Rot, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061405 · Cited by 321
Chemokine Up-Regulation and Activated T Cell Attraction by Maturing Dendritic Cells
Tang, H. L., & Cyster, J. G. (1999) · Science · doi:10.1126/science.284.5415.819 · Cited by 308
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines
Zhou, G., Drake, C. G., & Levitsky, H. I. (2006) · Blood · doi:10.1182/blood-2005-07-2737 · Cited by 272
Regulatory T cells and treatment of cancer
Curiel, T. J. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.04.008 · Cited by 262
Dendritic cells as a major source of macrophage-derived chemokine/CCL22in vitro andin vivo
Vulcano, M., Albanesi, C., Stoppacciaro, A., Bagnati, R., D'Amico, G., Struyf, S., Transidico, P., Bonecchi, R., Del Prete, A., Allavena, P., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200103)31:3<812::aid-immu812>3.0.co;2-l · Cited by 252
CCR4 as a novel molecular target for immunotherapy of cancer
Ishida, T., & Ueda, R. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00307.x · Cited by 247
Regulatory T‐cell homeostasis: steady‐state maintenance and modulation during inflammation
Smigiel, K. S., Srivastava, S., Stolley, J. M., & Campbell, D. J. (2014) · Immunological Reviews · doi:10.1111/imr.12170 · Cited by 222
Compartmentalized Production of CCL17 In Vivo
Alferink, J., Lieberam, I., Reindl, W., Behrens, A., Weiß, S., Hüser, N., Gerauer, K., Ross, R., Reske-Kunz, A. B., Ahmad-Nejad, P., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021859 · Cited by 194
Macrophage-derived chemokine (MDC)
Mantovani, A., Gray, P. A., Van Damme, J., & Sozzani, S. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.3.400 · Cited by 186
Schajnovitz, A., Itkin, T., D'Uva, G., Kalinkovich, A., Golan, K., Ludin, A., Cohen, D., Shulman, Z., Avigdor, A., Nagler, A., et al. (2011) · Nature Immunology · doi:10.1038/ni.2017 · Cited by 168
Pere, H., Montier, Y., Bayry, J., Quintin-Colonna, F., Merillon, N., Dransart, E., Badoual, C., Gey, A., Ravel, P., Marcheteau, E., et al. (2011) · Blood · doi:10.1182/blood-2011-01-329656 · Cited by 166
Schaniel, C., Pardali, E., Sallusto, F., Speletas, M., Ruedl, C., Shimizu, T., Seidl, T., Andersson, J., Melchers, F., Rolink, A. G., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.451 · Cited by 148
CCR4-dependent regulatory T cell function in inflammatory bowel disease
Yuan, Q., Bromley, S. K., Means, T. K., Jones, K. J., Hayashi, F., Bhan, A. K., & Luster, A. D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062076 · Cited by 143
Bayry, J., Tchilian, E. Z., Davies, M. N., Forbes, E. K., Draper, S. J., Kaveri, S. V., Hill, A. V. S., Kazatchkine, M. D., Beverley, P. C. L., Flower, D. R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803453105 · Cited by 126
Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets
Montané, J., Bischoff, L., Soukhatcheva, G., Dai, D. L., Hardenberg, G., Levings, M. K., Orban, P. C., Kieffer, T. J., Tan, R., & Verchere, C. B. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43048 · Cited by 121
Campbell, J. J., O’Connell, D. J., & Wurbel, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3358 · Cited by 119
Scimone, M. L., Felbinger, T. W., Mazo, I. B., Stein, J. V., von Andrian, U. H., & Weninger, W. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031645 · Cited by 116
Halin, C., Scimone, M. L., Bonasio, R., Gauguet, J.-M., Mempel, T. R., Quackenbush, E. J., Proia, R. L., MANDALA, S. M., & von Andrian, U. H. (2005) · Blood · doi:10.1182/blood-2004-09-3687 · Cited by 112
Heiseke, A. F., Faul, A., Lehr, H., Förster, I., Schmid, R., Krug, A., & Reindl, W. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.027 · Cited by 112
Boehm, F., Martin, M. P., Kesselring, R., Schiechl, G., Geissler, E. K., Schlitt, H. J., & Fichtner‐Feigl, S. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-97 · Cited by 99
D’Ambrosio, D., Albanesi, C., Lang, R., Girolomoni, G., Sinigaglia, F., & Laudanna, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2303 · Cited by 95
Vitali, C., Mingozzi, F., Broggi, A., Barresi, S., Zolezzi, F., Bayry, J., Raimondi, G., Zanoni, I., & Granucci, F. (2012) · Blood · doi:10.1182/blood-2011-09-379776 · Cited by 87
Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
Laplagne, C., Domagala, M., Naour, A. L., Quémerais, C., Hamel, D., Fournié, J., Couderc, B. C., Bousquet, C., Ferrand, A., & Poupot, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194719 · Cited by 86
Rapp, M., Grassmann, S. A., Chaloupka, M., Layritz, P., Krüger, S., Ormanns, S., Rataj, F., Janssen, K., Endres, S., Anz, D., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1105428 · Cited by 76
Self-citationFisher, J. D., Zhang, W., Balmert, S. C., Aral, A. M., Acharya, A. P., Külahçı, Y., Li, J., Turnquist, H. R., Thomson, A. W., Solari, M. G., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax8429 · Cited by 63
Cutting Edge: CCR4 Mediates Antigen-Primed T Cell Binding to Activated Dendritic Cells
Wu, M.-T., Fang, H., & Hwang, S. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.4791 · Cited by 50
Iellem, A., Colantonio, L., Bhakta, S., Sozzani, S., Mantovani, A., Sinigaglia, F., & D’Ambrosio, D. (2000) · European Journal of Immunology · Cited by 48
Ritprajak, P., Kaewraemruaen, C., & Hirankarn, N. (2019) · Cells · doi:10.3390/cells8101291 · Cited by 44
Laurikainen, H., Vuorela, A., Toivonen, A., Reinert‐Hartwall, L., Trontti, K., Lindgren, M., Keinänen, J., Mäntylä, T. J. S., Paju, J., Ilonen, T., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0776-z · Cited by 33
Nahle, S., Cassidy, H., Leroux, M., Mercier, R., Ghanbaja, J., Doumandji, Z. M., Matallanas, D., Rihn, B. H., Joubert, O., & Ferrari, L. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-0587-7 · Cited by 28
Hao, S., Han, X., Wang, D., Yang, Y., Li, Q., Li, X., & Qiu, C. (2016) · Immunology · doi:10.1111/imm.12596 · Cited by 17
Cited by
Li, C., Jiang, P., Wei, S., Xu, X., & Wang, J. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01234-1 · Cited by 921
Chemokines and the immune response to cancer
Ozga, A. J., Chow, M. T., & Luster, A. D. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.012 · Cited by 830
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 682
Luo, H., Xia, X., Huang, L.-B., An, H., Cao, M., Kim, G. D., Chen, H.-N., Zhang, W.-H., Shu, Y., Kong, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34395-2 · Cited by 567
Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages
Ochocka, N., Segit, P., Walentynowicz, K. A., Wojnicki, K., Cyranowski, S., Swatler, J., Mieczkowski, J., & Kaminska, B. (2021) · Nature Communications · doi:10.1038/s41467-021-21407-w · Cited by 471
Metadata
- Authors
- Rapp, M., Wintergerst, M. W. M., Kunz, W. G., Vetter, V. K., Knott, M. M. L., Lisowski, D., Haubner, S., Moder, S., Thaler, R., Eiber, S., Meyer, B., Röhrle, N., Piseddu, I., Grassmann, S., Layritz, P., Kühnemuth, B., Stutte, S., Bourquin, C., von Andrian, U. H., Endres, S., & Anz, D.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2019-03-25
- Volume
- 216
- Issue
- 5
- Pages
- 1170-1181
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2944125141
- Cited by
- 271
- References
- 62
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.